Asep Medical Holdings INC F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
ASEP Medical Holdings Inc. files for a U.S. IPO to fund the development of its sepsis diagnostics and anti-biofilm therapeutics, seeking a Nasdaq listing.
ASEP Medical Holdings Inc. plans a U.S. initial public offering to fund its diagnostic and therapeutic solutions for combating antibiotic failure.
ASEP Medical Holdings Inc. is seeking to raise capital through an initial public offering in the U.S. to advance its diagnostic and therapeutic solutions targeting antibiotic failure, sepsis, and biofilm infections.